152 related articles for article (PubMed ID: 25834441)
1. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.
Farnia V; Shirzadifar M; Shakeri J; Rezaei M; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2015; 11():625-35. PubMed ID: 25834441
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD.
Farnia V; Hojatitabar S; Shakeri J; Rezaei M; Yazdchi K; Bajoghli H; Holsboer-Trachsler E; Brand S
Pharmacopsychiatry; 2015 Jul; 48(4-5):156-63. PubMed ID: 26098128
[TBL] [Abstract][Full Text] [Related]
3. Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy-results from a double-blind, randomized, placebo-controlled clinical trial.
Farnia V; Tatari F; Alikhani M; Shakeri J; Taghizadeh M; Karbasizadeh H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
Drug Alcohol Depend; 2017 Jul; 176():117-125. PubMed ID: 28531768
[TBL] [Abstract][Full Text] [Related]
4. Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy - results from a double-blind, randomized, and placebo-controlled trial.
Farnia V; Tatari F; Alikhani M; Yazdchi K; Taghizadeh M; Sadeghi Bahmani D; Karbasizadeh H; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2017 Dec; 95():260-268. PubMed ID: 28923720
[TBL] [Abstract][Full Text] [Related]
5. Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial.
Shahmoradi N; Davarinejad O; Brühl AB; Brand S
Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763782
[No Abstract] [Full Text] [Related]
6. Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial.
Niazi M; Hashempur MH; Taghizadeh M; Heydari M; Shariat A
Complement Ther Med; 2017 Oct; 34():35-41. PubMed ID: 28917373
[TBL] [Abstract][Full Text] [Related]
7. The effect of vilazodone on sexual function during the treatment of major depressive disorder.
Clayton AH; Kennedy SH; Edwards JB; Gallipoli S; Reed CR
J Sex Med; 2013 Oct; 10(10):2465-76. PubMed ID: 23216998
[TBL] [Abstract][Full Text] [Related]
8. In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder.
Haghighi M; Khodakarami S; Jahangard L; Ahmadpanah M; Bajoghli H; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2014 Nov; 58():109-14. PubMed ID: 25130678
[TBL] [Abstract][Full Text] [Related]
9. Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder.
Umbricht D; Niggli M; Sanwald-Ducray P; Deptula D; Moore R; Grünbauer W; Boak L; Fontoura P
J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32663909
[TBL] [Abstract][Full Text] [Related]
10. Novel Effects of
Esfandiary E; Abdolali Z; Omranifard V; Ghanadian M; Bagherian-Sararoud R; Karimipour M; Mahaki B; Dabiri S
Int J Prev Med; 2018; 9():57. PubMed ID: 30050668
[TBL] [Abstract][Full Text] [Related]
11. The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial.
Seidman SN; Roose SP
J Sex Marital Ther; 2006; 32(3):267-73. PubMed ID: 16809253
[TBL] [Abstract][Full Text] [Related]
12. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
13. Assessing the effect of
Akbarzadeh F; Eslamzadeh M; Behravan G; Ebrahimi A; Emami SA; Gilan A; Hoseinian NS
Front Psychiatry; 2023; 14():1105828. PubMed ID: 37143784
[TBL] [Abstract][Full Text] [Related]
14. Influence of adjuvant omega-3-polyunsaturated fatty acids on depression, sleep, and emotion regulation among outpatients with major depressive disorders - Results from a double-blind, randomized and placebo-controlled clinical trial.
Jahangard L; Sadeghi A; Ahmadpanah M; Holsboer-Trachsler E; Sadeghi Bahmani D; Haghighi M; Brand S
J Psychiatr Res; 2018 Dec; 107():48-56. PubMed ID: 30317101
[TBL] [Abstract][Full Text] [Related]
15. Investigating the effect of magnesium supplement in patients with major depressive disorder under selective serotonin reuptake inhibitor treatment.
Nazarinasab M; Behrouzian F; Abdi L; Sadegh Moghaddam AA; Sadeghi S
J Family Med Prim Care; 2022 Dec; 11(12):7800-7805. PubMed ID: 36994048
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.
Ghaleiha A; Davari H; Jahangard L; Haghighi M; Ahmadpanah M; Seifrabie MA; Bajoghli H; Holsboer-Trachsler E; Brand S
Eur Arch Psychiatry Clin Neurosci; 2016 Dec; 266(8):695-702. PubMed ID: 26984349
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of
Moravej SAA; Shojaii A; Hashem Dabaghian F; Jazayeri SF; Moravej SZ; Khadem E; Agah S; Ghods R
Evid Based Complement Alternat Med; 2021; 2021():6628911. PubMed ID: 34422077
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.
Atmaca M; Korkmaz S; Topuz M; Mermi O
Psychiatry Investig; 2011 Mar; 8(1):55-7. PubMed ID: 21519537
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
20. The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men.
Fabre LF; Clayton AH; Smith LC; Goldstein I; Derogatis LR
J Sex Med; 2012 Mar; 9(3):821-9. PubMed ID: 22240272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
